다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

EDIT

Editas Medicine (EDIT)

Editas Medicine Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EDIT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/05/10	19:00	GlobeNewswire Inc.	Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:EDIT	Editas Medicine Inc
2024/05/09	05:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	21:29	IH Market News	U.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices Fall	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	20:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	20:00	GlobeNewswire Inc.	Editas Medicine Announces First Quarter 2024 Results and Business Updates	NASDAQ:EDIT	Editas Medicine Inc
2024/05/02	20:00	GlobeNewswire Inc.	Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events	NASDAQ:EDIT	Editas Medicine Inc
2024/05/01	21:00	GlobeNewswire Inc.	Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration	NASDAQ:EDIT	Editas Medicine Inc
2024/04/23	05:31	GlobeNewswire Inc.	Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/05	07:58	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/02/29	07:13	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:EDIT	Editas Medicine Inc
2024/02/29	06:39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EDIT	Editas Medicine Inc
2024/02/28	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/02/28	21:00	GlobeNewswire Inc.	Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates	NASDAQ:EDIT	Editas Medicine Inc
2024/02/21	21:00	GlobeNewswire Inc.	Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events	NASDAQ:EDIT	Editas Medicine Inc
2024/02/14	22:40	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:EDIT	Editas Medicine Inc
2024/01/31	23:00	GlobeNewswire Inc.	Editas Medicine to Participate in Upcoming Investor Conferences	NASDAQ:EDIT	Editas Medicine Inc
2024/01/08	22:15	GlobeNewswire Inc.	Editas Medicine Highlights 2024 Anticipated Milestones and Strategic Priorities at the J.P. Morgan Healthcare Conference	NASDAQ:EDIT	Editas Medicine Inc
2024/01/03	21:00	GlobeNewswire Inc.	Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:EDIT	Editas Medicine Inc
2023/12/14	02:48	Dow Jones News	Editas Medicine Strikes License Deal With Vertex Pharmaceuticals -- Update	NASDAQ:EDIT	Editas Medicine Inc
2023/12/13	23:49	Dow Jones News	Editas Medicine Strikes License Deal With Vertex Pharmaceuticals	NASDAQ:EDIT	Editas Medicine Inc
2023/12/13	23:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2023/12/13	23:00	GlobeNewswire Inc.	Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9	NASDAQ:EDIT	Editas Medicine Inc
2023/12/12	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2023/12/12	02:00	GlobeNewswire Inc.	Editas Medicine Announces New EDIT-301 Safety and Efficacy Data in 17 Patients, Presented Today at the American Society of Hematology (ASH) Annual Meeting and in a Company-sponsored Webinar	NASDAQ:EDIT	Editas Medicine Inc
2023/12/08	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc

검색 관련기사 보기:NASDAQ:EDIT

1 2 3 4 5 6 7 8 9 10 다음 >>

Tego Cyber (QB)

Sg Etc Daily Long 2x Bre...

Invesco S&P MidCap 400 P...

Jpmorgan Chase Financial...

Prime Meridian (QX)

Gabelli Dividend and Inc...

RAM Essential Services P...

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관